Amr

(Image: Getty/AndreyPopov)

Mundipharma bets $568m on antifungal treatment

By Ben Hargreaves

Mundipharma signs agreement to progress an antifungal candidate through to commercialization, with the potential for it to become the first approved treatment in 13 years.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers